• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Clinical trial could change standard treatment for stroke

, 26 August 2020/in E-News /by 3wmedia

A large international clinical trial has shed new light on the effectiveness of current hospital protocols for managing blood pressure in stroke patients.

The two-part ENOS trial (Efficacy of Nitric Oxide in Stroke,) was carried out at The University of Nottingham in collaboration with 23 countries to try to solve two major conundrums faced by doctors when treating people who have suffered a stroke

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:40:09Clinical trial could change standard treatment for stroke

Shape-shifting sensor can report conditions from deep in the body

, 26 August 2020/in E-News /by 3wmedia

Novel geometrically encoded magnetic sensors (GEMs), developed by researchers from NIST and NIH, respond to local biochemical conditions

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:49Shape-shifting sensor can report conditions from deep in the body

Unfors RaySafe signs exclusive agreement with Philips on dose management System

, 26 August 2020/in E-News /by 3wmedia

Unfors RaySafe, acquired by Fluke Biomedical in February 2014, has signed an exclusive agreement with Philips to license out the Patient Dose Management System RaySafe S1. The RaySafe S1 is a cloud-based patient dose tracking system launched in 2013 that helps healthcare institutions lower patient dose, improve process quality and increase productivity in imaging workflow while reducing costs. In an effort to accelerate market reach and better support healthcare institutions to avoid unnecessary radiation RaySafe has searched for a strong partner. Philips is launching groundbreaking initiatives to provide solutions that lower dose and create a safer environment for patients as well as medical staff.

Each year approximately 3.6 billion X-ray examinations are performed worldwide, leading to earlier and more accurate diagnosis of medical diseases. However, considerable concern has been voiced regarding the stochastic and even deterministic impact on both patients and medical staff. It is critical to ensuring the proper performance of X-ray equipment and of keeping the dose to medical staff and patients as low as reasonably achievable (ALARA).

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:57Unfors RaySafe signs exclusive agreement with Philips on dose management System

Tablet-based ultrasound trial shows lifesaving potential in emergency services

, 26 August 2020/in E-News /by 3wmedia

The preliminary results of a groundbreaking trial into the use of tablet-based ultrasound in emergency services vehicles have been released in late October. A total of six emergency services vehicles at Bedford, Hurst and DFW Airport Fire Departments in the Dallas-Fort Worth metropolitan area have been equipped with Samsung

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:40:05Tablet-based ultrasound trial shows lifesaving potential in emergency services

?Dead? heart transplant ?huge breakthrough?

, 26 August 2020/in E-News /by 3wmedia

In a world first, Australian surgeons have successfully transplanted

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:39:52?Dead? heart transplant ?huge breakthrough?

Scientists find way to boost healthy cells during chemo

, 26 August 2020/in E-News /by 3wmedia

It

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:40:00Scientists find way to boost healthy cells during chemo

For stroke patients, hospital bed position is a delicate balancing act

, 26 August 2020/in E-News /by 3wmedia

During the first 24 hours after a stroke, attention to detail – such as hospital bed positioning – is critical to patient outcomes.

Most strokes are caused by blood clots that block blood flow to the brain. Sitting upright can harm the patient because it decreases blood flow and oxygen to the brain just when the brain needs more blood.

Thus it

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:472020-08-26 14:40:07For stroke patients, hospital bed position is a delicate balancing act

Hybrid cochlear implants for common form of hearing loss may benefit millions

, 26 August 2020/in E-News /by 3wmedia

People with a common form of hearing loss not helped by hearing aids achieved significant and sometimes profound improvements in their hearing and understanding of speech with hybrid cochlear implant devices, according to a new multicenter study led by specialists at NYU Langone Medical Center.

In the study researchers at 10 medical centres and private clinics in the United States implanted hybrid cochlear implants into one ear of 50 men and women. All study volunteers had badly damaged high-frequency, inner-ear hair cells, which prevented them from understanding speech, especially in the presence of background noise. All still had sufficient low-frequency hearing, which allowed them to tell apart some sounds and forestalled any use of a regular cochlear implant.

A year after receiving the device, 45 study participants showed overall improvement in their hearing and speech recognition, and no one

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:22Hybrid cochlear implants for common form of hearing loss may benefit millions

Withholding angiotensin receptor blockers after surgery increases risk of postoperative death

, 26 August 2020/in E-News /by 3wmedia

Withholding angiotensin receptor blockers (ARBs) for longer than two days after surgery is associated with a significantly increased risk of postoperative death, according to a study of more than 30,000 patients in the VA health care system by researchers at UC San Francisco and the San Francisco VA Medical Center (SFVAMC).

ARBs are prescribed for high blood pressure, heart disease and kidney disease, explained lead author Susan M. Lee, MD, an SFVAMC anesthesiologist and UCSF clinical instructor.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:30Withholding angiotensin receptor blockers after surgery increases risk of postoperative death

Shift from IV to oral sedation for pain procedures?

, 26 August 2020/in E-News /by 3wmedia

The transition from extensive use of intravenous (IV) sedation for interventional pain procedures to almost exclusive use of oral anxiolysis at an outpatient pain centre led to significant improvements in patient satisfaction and recovery times, a new study shows.
But not all practitioners are on board with such a policy, citing potential safety issues.

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:39:222020-08-26 14:39:37Shift from IV to oral sedation for pain procedures?
Page 141 of 240«‹139140141142143›»

Latest issue of International Hospital

April 2024

7 January 2026

Gulf Aorta Summit 2026 Returns to Dubai with a Global Lineup of Aortic Experts

17 December 2025

GE HealthCare receives CE mark for 128cm total body PET/CT

16 December 2025

HOPS 2026 Returns to Dubai — Setting a New Benchmark for Oncology Pharmacy in the Middle East

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription